Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023
HR 3355 reauthorizes a federal program providing loan repayment assistance to healthcare professionals working in substance use disorder (SUD) treatment. It makes these repayments tax-free under the Internal Revenue Code and requires detailed annual reporting on applicants, including those denied due to insufficient funding. The program is funded at $75 million annually for fiscal years 2024-2028. This directly supports clinicians in SUD treatment who have student loan debt, helping address workforce shortages in addiction care.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2023
Committee Review
Floor Vote
President
Introduced May 16, 2023
Last action Dec 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Dec 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 19, 2023
Committee
Referred to the Subcommittee on Health.
lower
May 16, 2023
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 16, 2023
Introduced
Introduced in House
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3355
Scope: US
Hi! I can help you understand HR 3355. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline